Pfizer Vaccine Manufacturing Capacity

The breadth of this program should allow production of millions of vaccine doses in 2020 increasing to hundreds of millions in 2021.

Pfizer vaccine manufacturing capacity. Pfizer plans to activate its extensive manufacturing network and invest at risk in an effort to produce an approved covid 19 vaccine as quickly as possible for those most in need around the world. Mcdermott said pfizer will also add additional shifts to its own factories hire more. Now pfizer on top its own. Pfizer had already said it had chosen sites in kalamazoo andover massachusetts and st louis for its us covid 19 production.

Pfizer hopes to deliver 100 million vaccine doses in 2020 and 1 3 billion next year. Pfizer and biontech to jointly develop covid 19 vaccine initially in the united states and europe and scale up manufacturing capacity to support global supply potential to supply millions of vaccine doses by the end of 2020 subject to technical success of the development program and approval by regulatory authorities and then rapidly scale up capacity to produce hundreds of millions of doses in 2021. Biontech and pfizer will also work jointly to commercialise the vaccine worldwide excluding china which is already covered by biontech s collaboration with fosun pharma upon regulatory approval. Pfizer too has been scaling up manufacturing for months ordering new equipment and buying raw materials.

Many organizations and companies in the biopharma world have formed alliances to develop drugs and vaccines against the novel coronavirus amid a global pandemic. Sahin said is expected to ramp up covid 19 vaccine manufacturing capacity to 750 million doses a year by late 2021. In all pfizer expects deliveries to take three days. Biontech and pfizer will work together to scale up manufacturing capacity at risk to provide worldwide supply in response to the pandemic.

Nyse pfe today announced it has signed a 10 year provisional supply agreement to supply prevenar 13 pneumococcal polysaccharide conjugate vaccine 13 valent adsorbed the company s 13 valent pneumococcal conjugate vaccine for infants and young children in the world s poorest countries under the terms of the advance market commitment amc pilot project. Pfizer currently produces around 1 5 billion doses of intravenously injected vaccines and drugs each year.